Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Neurotech International Limited
  6. Summary
    NTI   AU000000NTI9

NEUROTECH INTERNATIONAL LIMITED

(NTI)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
0.042 0.042 0.039 0.042 0.044 Last
239028 1277616 975741 398142 1200926 Volume
-6.67% 0.00% -7.14% +7.69% +4.76% Change
Estimated financial data (e)
Sales 2020 0,08 M 0,06 M 0,06 M
Net income 2020 -1,71 M -1,24 M -1,24 M
Net Debt 2020 0,04 M 0,03 M 0,03 M
P/E ratio 2020 -0,72x
Yield 2020 -
Sales 2021 0,23 M 0,16 M 0,16 M
Net income 2021 -7,43 M -5,39 M -5,39 M
Net cash position 2021 4,83 M 3,50 M 3,50 M
P/E ratio 2021 -3,51x
Yield 2021 -
Capitalization 30,7 M 22,2 M 22,3 M
EV / Sales 2020 22,0x
EV / Sales 2021 142x
Nbr of Employees -
Free-Float 98,1%
More Financials
Company
Neurotech International Limited is an Australia-based medical device and solutions company. The Company operates through its wholly owned, Malta-based subsidiary AAT Research Limited. The Company is focusing on neuro-protective, anti-inflammatory and neuro-modulatory activities of NTI/Dolce cannabis strains. The Company through its class II device Mente is focused on development and commercialisation of... 
More about the company
All news about NEUROTECH INTERNATIONAL LIMITED
08/29Neurotech International Limited Reports Earnings Results for the Full Year Ended June 3..
CI
07/06Neurotech International Limited Announces Preclinical Testing Program - Multiple Sclero..
CI
05/24Neurotech International Limited Announces the Continuation of Its Pre-Clinical Program ..
CI
05/19Neurotech International Limited Appoints Allan Cripps as Non-Executive Director
CI
05/04Neurotech International Limited Initiates Phase I/II Open Label Study into Autism
CI
04/05Neurotech International Limited Appoints Krista Bates as Non-Executive Director, Effect..
CI
03/30Neurotech International Limited Announces Human Clinical Trial Update
CI
03/08Neurotech International Limited Announces Strategic Cultivation Partnership with CannaP..
CI
03/01Neurotech International Limited Announces the Expansion of Its Exclusive License with D..
CI
02/25Neurotech International Limited Reports Earnings Results for the Half Year Ended Decemb..
CI
02/14Neurotech International Limited Provides an Update on Clinical Study Program
CI
2020Neurotech International's DOLCE/NTI Strains Exhibit 'Potent' Anti-Inflammatory Activity..
MT
2020Neurotech International Limited Announces Successful Completion of in Vitro Studies
CI
2020NEUROTECH INTERNATIONAL : Crucial Lab Results Are Imminent, Will Neurotech Rerate?
AQ
2020Neurotech International Limited Announces Further Preliminary Results of In-Vitro Human..
CI
More news
News in other languages on NEUROTECH INTERNATIONAL LIMITED

- No features available -

More news
Chart NEUROTECH INTERNATIONAL LIMITED
Duration : Period :
Neurotech International Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEUROTECH INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers and Directors
Brian Leedman Non-Executive Chairman
Winton William Willesee Independent Non-Executive Director
Erlyn Dale Director & Secretary
Krista Bates Non-Executive Director
Allan Cripps Non-Executive Director
Sector and Competitors